vs
Biofrontera Inc.（BFRI）与KKR Real Estate Finance Trust Inc.（KREF）财务数据对比。点击上方公司名可切换其他公司
KKR Real Estate Finance Trust Inc.的季度营收约是Biofrontera Inc.的1.5倍（$25.8M vs $17.1M），Biofrontera Inc.净利率更高（33.0% vs -101.7%，领先134.7%），Biofrontera Inc.同比增速更快（36.2% vs -26.6%），过去两年Biofrontera Inc.的营收复合增速更高（47.0% vs -18.8%）
Biofrontera Inc.是一家专注于皮肤病治疗领域的特种生物制药企业，主要研发和商业化处方类皮肤科药物，核心产品线针对光化性角化病等常见皮肤病症，主要市场覆盖美国及欧盟地区，服务皮肤科医护人员与患者。
KKR房地产金融信托公司是全球投资机构KKR旗下的专业房地产金融平台，主要发起、收购并管理优先担保商业地产贷款组合，抵押物多为美国各地的优质机构级商业地产，通过贷款利息收入为投资者提供稳定的经风险调整后的回报。
BFRI vs KREF — 直观对比
营收规模更大
KREF
是对方的1.5倍
$17.1M
营收增速更快
BFRI
高出62.7%
-26.6%
净利率更高
BFRI
高出134.7%
-101.7%
两年增速更快
BFRI
近两年复合增速
-18.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $17.1M | $25.8M |
| 净利润 | $5.6M | $-26.2M |
| 毛利率 | — | — |
| 营业利润率 | 26.6% | -105.1% |
| 净利率 | 33.0% | -101.7% |
| 营收同比 | 36.2% | -26.6% |
| 净利润同比 | 504.0% | -229.6% |
| 每股收益（稀释后） | $0.62 | $-0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BFRIKREF
| Q4 25 | $17.1M | $25.8M | ||
| Q3 25 | $7.0M | $25.3M | ||
| Q2 25 | $9.0M | $30.2M | ||
| Q1 25 | $8.6M | $31.3M | ||
| Q4 24 | $12.6M | $35.1M | ||
| Q3 24 | $9.0M | $37.0M | ||
| Q2 24 | $7.8M | $40.4M | ||
| Q1 24 | $7.9M | $39.1M |
净利润BFRIKREF
| Q4 25 | $5.6M | $-26.2M | ||
| Q3 25 | $-6.6M | $13.8M | ||
| Q2 25 | $-5.3M | $-29.7M | ||
| Q1 25 | $-4.2M | $-4.9M | ||
| Q4 24 | $-1.4M | $20.3M | ||
| Q3 24 | $-5.7M | $-7.4M | ||
| Q2 24 | $-257.0K | $25.8M | ||
| Q1 24 | $-10.4M | $-3.1M |
营业利润率BFRIKREF
| Q4 25 | 26.6% | -105.1% | ||
| Q3 25 | -89.8% | 50.4% | ||
| Q2 25 | -56.2% | -101.3% | ||
| Q1 25 | -52.9% | -18.3% | ||
| Q4 24 | -13.6% | 55.8% | ||
| Q3 24 | -55.0% | -19.6% | ||
| Q2 24 | -64.7% | 63.3% | ||
| Q1 24 | -69.1% | -8.7% |
净利率BFRIKREF
| Q4 25 | 33.0% | -101.7% | ||
| Q3 25 | -95.1% | 54.4% | ||
| Q2 25 | -59.0% | -98.5% | ||
| Q1 25 | -48.9% | -15.5% | ||
| Q4 24 | -11.1% | 57.7% | ||
| Q3 24 | -62.9% | -20.0% | ||
| Q2 24 | -3.3% | 63.9% | ||
| Q1 24 | -131.9% | -7.9% |
每股收益（稀释后）BFRIKREF
| Q4 25 | $0.62 | $-0.49 | ||
| Q3 25 | $-0.62 | $0.12 | ||
| Q2 25 | $-0.57 | $-0.53 | ||
| Q1 25 | $-0.47 | $-0.15 | ||
| Q4 24 | $0.69 | $0.22 | ||
| Q3 24 | $-0.98 | $-0.19 | ||
| Q2 24 | $-0.05 | $0.29 | ||
| Q1 24 | $-2.88 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.4M | $84.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $10.5M | $1.2B |
| 总资产 | $28.6M | $6.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BFRIKREF
| Q4 25 | $6.4M | $84.6M | ||
| Q3 25 | $3.4M | $204.1M | ||
| Q2 25 | $7.2M | $107.7M | ||
| Q1 25 | $1.8M | $106.4M | ||
| Q4 24 | $5.9M | $104.9M | ||
| Q3 24 | $2.9M | $108.8M | ||
| Q2 24 | $4.4M | $107.2M | ||
| Q1 24 | $3.8M | $106.5M |
股东权益BFRIKREF
| Q4 25 | $10.5M | $1.2B | ||
| Q3 25 | $-2.6M | $1.2B | ||
| Q2 25 | $-4.7M | $1.2B | ||
| Q1 25 | $500.0K | $1.3B | ||
| Q4 24 | $4.4M | $1.3B | ||
| Q3 24 | $5.5M | $1.4B | ||
| Q2 24 | $10.9M | $1.4B | ||
| Q1 24 | $-5.4M | $1.4B |
总资产BFRIKREF
| Q4 25 | $28.6M | $6.5B | ||
| Q3 25 | $15.4M | $6.5B | ||
| Q2 25 | $20.1M | $6.8B | ||
| Q1 25 | $16.6M | $6.6B | ||
| Q4 24 | $22.1M | $6.4B | ||
| Q3 24 | $18.5M | $6.8B | ||
| Q2 24 | $21.6M | $7.1B | ||
| Q1 24 | $24.6M | $7.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.4M | $72.3M |
| 自由现金流经营现金流 - 资本支出 | $-2.4M | — |
| 自由现金流率自由现金流/营收 | -13.9% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | -0.42× | — |
| 过去12个月自由现金流最近4个季度 | $-13.4M | — |
8季度趋势，按日历期对齐
经营现金流BFRIKREF
| Q4 25 | $-2.4M | $72.3M | ||
| Q3 25 | $-3.8M | $18.5M | ||
| Q2 25 | $-3.0M | $21.1M | ||
| Q1 25 | $-4.1M | $15.9M | ||
| Q4 24 | $-1.0M | $132.6M | ||
| Q3 24 | $-1.2M | $49.1M | ||
| Q2 24 | $-4.7M | $30.6M | ||
| Q1 24 | $-3.3M | $34.5M |
自由现金流BFRIKREF
| Q4 25 | $-2.4M | — | ||
| Q3 25 | $-3.8M | — | ||
| Q2 25 | $-3.0M | — | ||
| Q1 25 | $-4.1M | — | ||
| Q4 24 | $-1.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-4.8M | — | ||
| Q1 24 | $-3.4M | — |
自由现金流率BFRIKREF
| Q4 25 | -13.9% | — | ||
| Q3 25 | -54.7% | — | ||
| Q2 25 | -33.7% | — | ||
| Q1 25 | -48.0% | — | ||
| Q4 24 | -8.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -60.8% | — | ||
| Q1 24 | -42.7% | — |
资本支出强度BFRIKREF
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.7% | — |
现金转化率BFRIKREF
| Q4 25 | -0.42× | — | ||
| Q3 25 | — | 1.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.54× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.19× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
